Published in Blood on July 18, 2011
Functions of S100 proteins. Curr Mol Med (2013) 2.43
Annexin A2 heterotetramer: structure and function. Int J Mol Sci (2013) 1.17
Plasminogen receptors: the first quarter century. Semin Thromb Hemost (2013) 1.09
Bacterial plasminogen receptors utilize host plasminogen system for effective invasion and dissemination. J Biomed Biotechnol (2012) 1.01
So many plasminogen receptors: why? J Biomed Biotechnol (2012) 0.98
The annexin A2/S100A10 system in health and disease: emerging paradigms. J Biomed Biotechnol (2012) 0.96
Annexin A2 system in human biology: cell surface and beyond. Semin Thromb Hemost (2013) 0.92
Dynamic reciprocity: the role of annexin A2 in tissue integrity. J Cell Commun Signal (2014) 0.90
New insights into the role of Plg-RKT in macrophage recruitment. Int Rev Cell Mol Biol (2014) 0.89
The biochemistry and regulation of S100A10: a multifunctional plasminogen receptor involved in oncogenesis. J Biomed Biotechnol (2012) 0.87
Annexin A2 complexes with S100 proteins: structure, function and pharmacological manipulation. Br J Pharmacol (2014) 0.87
Annexin A2: the importance of being redox sensitive. Int J Mol Sci (2013) 0.86
Age-related and depot-specific changes in white adipose tissue of growth hormone receptor-null mice. J Gerontol A Biol Sci Med Sci (2013) 0.84
Three-dimensional pharmacophore design and biochemical screening identifies substituted 1,2,4-triazoles as inhibitors of the annexin A2-S100A10 protein interaction. ChemMedChem (2012) 0.83
The Biology of Annexin A2: From Vascular Fibrinolysis to Innate Immunity. Trans Am Clin Climatol Assoc (2015) 0.80
Design, synthesis and SAR exploration of tri-substituted 1,2,4-triazoles as inhibitors of the annexin A2-S100A10 protein interaction. Bioorg Med Chem (2014) 0.79
Ceramide 1-phosphate mediates endothelial cell invasion via the annexin a2-p11 heterotetrameric protein complex. J Biol Chem (2013) 0.79
Recent advances in disseminated intravascular coagulation: endothelial cells and fibrinolysis in sepsis-induced DIC. J Intensive Care (2015) 0.78
Characterization of plasminogen binding to NB4 promyelocytic cells using monoclonal antibodies against receptor-induced binding sites in cell-bound plasminogen. J Biomed Biotechnol (2012) 0.76
Cell- and region-specific expression of depression-related protein p11 (S100a10) in the brain. J Comp Neurol (2016) 0.75
Plasminogen-receptor KT : plasminogen activation and beyond. J Thromb Haemost (2016) 0.75
Deficiency of plasminogen receptor, Plg-RKT , causes defects in plasminogen binding and inflammatory macrophage recruitment in vivo. J Thromb Haemost (2016) 0.75
The concept of voluntary consent. Am J Bioeth (2011) 7.63
Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc Natl Acad Sci U S A (2004) 3.87
Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice. Nat Genet (2013) 2.62
How can drug discovery for psychiatric disorders be improved? Nat Rev Drug Discov (2007) 2.29
Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt. Cancer Res (2006) 2.13
Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification. Neurogenetics (2013) 2.11
Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens. Sci Transl Med (2010) 2.09
Adenosine and brain function. Int Rev Neurobiol (2005) 1.97
Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature (2002) 1.91
Phactrs 1-4: A family of protein phosphatase 1 and actin regulatory proteins. Proc Natl Acad Sci U S A (2004) 1.86
S100A10 regulates plasminogen-dependent macrophage invasion. Blood (2010) 1.85
Depression in Parkinson disease--epidemiology, mechanisms and management. Nat Rev Neurol (2011) 1.69
Peptidomics-based discovery of novel neuropeptides. J Proteome Res (2003) 1.65
Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs. Nat Neurosci (2008) 1.63
Role of p11 in cellular and behavioral effects of 5-HT4 receptor stimulation. J Neurosci (2009) 1.62
Systemic reovirus therapy of metastatic cancer in immune-competent mice. Cancer Res (2003) 1.59
The Rho-specific GEF Lfc interacts with neurabin and spinophilin to regulate dendritic spine morphology. Neuron (2005) 1.57
Fluoxetine administered to juvenile monkeys: effects on the serotonin transporter and behavior. Am J Psychiatry (2014) 1.54
Progestins regulate the expression and activity of the forkhead transcription factor FOXO1 in differentiating human endometrium. Mol Endocrinol (2005) 1.51
Heat stabilization of the tissue proteome: a new technology for improved proteomics. J Proteome Res (2009) 1.29
The role of 5-HT(1A) receptors in learning and memory. Behav Brain Res (2008) 1.28
The role of DARPP-32 in the actions of drugs of abuse. Neuropharmacology (2004) 1.27
Parent-child agreement regarding children's acute stress: the role of parent acute stress reactions. J Am Acad Child Adolesc Psychiatry (2006) 1.27
Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin. J Biol Chem (2003) 1.26
Phosphorylation of DARPP-32 at Threonine-34 is required for cocaine action. Neuropsychopharmacology (2006) 1.24
EuroInf: a multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson's disease. Mov Disord (2014) 1.23
Stakeholders' opinions on the implementation of pediatric whole exome sequencing: implications for informed consent. J Genet Couns (2013) 1.21
Neurogenic effects of fluoxetine are attenuated in p11 (S100A10) knockout mice. Biol Psychiatry (2010) 1.19
Decreased striatal levels of PEP-19 following MPTP lesion in the mouse. J Proteome Res (2006) 1.17
Molecular profiling of experimental Parkinson's disease: direct analysis of peptides and proteins on brain tissue sections by MALDI mass spectrometry. J Proteome Res (2004) 1.17
Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum. Proc Natl Acad Sci U S A (2004) 1.16
Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade. J Neurosci (2003) 1.15
Annexin A2 is a novel RNA-binding protein. J Biol Chem (2003) 1.11
RNA interference-mediated silencing of the S100A10 gene attenuates plasmin generation and invasiveness of Colo 222 colorectal cancer cells. J Biol Chem (2003) 1.10
Transcription factor Nurr1 maintains fiber integrity and nuclear-encoded mitochondrial gene expression in dopamine neurons. Proc Natl Acad Sci U S A (2013) 1.09
ICI182,780 induces p21Waf1 gene transcription through releasing histone deacetylase 1 and estrogen receptor alpha from Sp1 sites to induce cell cycle arrest in MCF-7 breast cancer cell line. J Biol Chem (2004) 1.09
Antidepressants reverse the attenuation of the neurotrophic MEK/MAPK cascade in frontal cortex by elevated platform stress; reversal of effects on LTP is associated with GluA1 phosphorylation. Neuropharmacology (2008) 1.08
Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons. J Neurosci (2005) 1.07
The significance of biochemical and molecular sample integrity in brain proteomics and peptidomics: stathmin 2-20 and peptides as sample quality indicators. Proteomics (2007) 1.07
p11 and its role in depression and therapeutic responses to antidepressants. Nat Rev Neurosci (2013) 1.07
Regulation of annexin A2 by reversible glutathionylation. J Biol Chem (2003) 1.06
Evidence for a role of the 5-HT1B receptor and its adaptor protein, p11, in L-DOPA treatment of an animal model of Parkinsonism. Proc Natl Acad Sci U S A (2008) 1.06
Pharmacology of adenosine A2A receptors and therapeutic applications. Curr Top Med Chem (2003) 1.04
Plasminogen receptor S100A10 is essential for the migration of tumor-promoting macrophages into tumor sites. Cancer Res (2011) 1.03
Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression. Int J Neuropsychopharmacol (2011) 1.03
DNA-PKCS binding to p53 on the p21WAF1/CIP1 promoter blocks transcription resulting in cell death. Oncotarget (2011) 1.01
The role of the annexin A2 heterotetramer in vascular fibrinolysis. Blood (2011) 1.00
Adenosine-dopamine interactions: development of a concept and some comments on therapeutic possibilities. Neurology (2003) 1.00
Physiological role for casein kinase 1 in glutamatergic synaptic transmission. J Neurosci (2005) 1.00
Serotonin-1A receptors in major depression quantified using PET: controversies, confounds, and recommendations. Neuroimage (2011) 0.99
A role for p11 in the antidepressant action of brain-derived neurotrophic factor. Biol Psychiatry (2010) 0.99
5-HT7 receptor stimulation by 8-OH-DPAT counteracts the impairing effect of 5-HT(1A) receptor stimulation on contextual learning in mice. Eur J Pharmacol (2008) 0.99
Co-expression of serotonin 5-HT(1B) and 5-HT(4) receptors in p11 containing cells in cerebral cortex, hippocampus, caudate-putamen and cerebellum. Neuropharmacology (2011) 0.97
p11 regulates extracellular plasmin production and invasiveness of HT1080 fibrosarcoma cells. FASEB J (2003) 0.94
S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo. J Pharmacol Exp Ther (2007) 0.94
Antipsychotic drugs regulate hedgehog signaling by modulation of 7-dehydrocholesterol reductase levels. Mol Pharmacol (2010) 0.94
Testicular tissue cryopreservation in prepubertal male children: an analysis of parental decision-making. Pediatr Blood Cancer (2014) 0.94
Crystallographic analysis of calcium-dependent heparin binding to annexin A2. J Biol Chem (2006) 0.93
Oxysterols and Parkinson's disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease. Neurosci Lett (2013) 0.92
Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson's disease and major depression. J Neurol (2009) 0.91
Annexin 2-mediated enhancement of cytomegalovirus infection opposes inhibition by annexin 1 or annexin 5. J Gen Virol (2007) 0.91
Hypersensitivity to chromium-induced DNA damage correlates with constitutive deregulation of upstream p53 kinases in p21-/- HCT116 colon cancer cells. DNA Repair (Amst) (2007) 0.91
Neuropeptidomics: MS applied to the discovery of novel peptides from the brain. Anal Chem (2007) 0.90
Chromium-mediated apoptosis: involvement of DNA-dependent protein kinase (DNA-PK) and differential induction of p53 target genes. DNA Repair (Amst) (2008) 0.89
Genetic deletion of trace amine 1 receptors reveals their role in auto-inhibiting the actions of ecstasy (MDMA). J Neurosci (2011) 0.89
Changes on 5-HT2 receptor mRNAs in striatum and subthalamic nucleus in Parkinson's disease model. Physiol Behav (2007) 0.89
Regulation of S100A10 by the PML-RAR-α oncoprotein. Blood (2011) 0.88
Mass spectrometry imaging, an emerging technology in neuropsychopharmacology. Neuropsychopharmacology (2013) 0.87
The biochemistry and regulation of S100A10: a multifunctional plasminogen receptor involved in oncogenesis. J Biomed Biotechnol (2012) 0.87
Deuterated matrix-assisted laser desorption ionization matrix uncovers masked mass spectrometry imaging signals of small molecules. Anal Chem (2012) 0.87
Striatal alterations of secretogranin-1, somatostatin, prodynorphin, and cholecystokinin peptides in an experimental mouse model of Parkinson disease. Mol Cell Proteomics (2009) 0.87
De novo mutations in ataxin-2 gene and ALS risk. PLoS One (2013) 0.86
(11)C-CUMI-101, a PET radioligand, behaves as a serotonin 1A receptor antagonist and also binds to α(1) adrenoceptors in brain. J Nucl Med (2014) 0.86
Annexin A2: the importance of being redox sensitive. Int J Mol Sci (2013) 0.86
MRI diffusion in Parkinson's disease: using the technique's inherent directional information to study the olfactory bulb and substantia nigra. J Parkinsons Dis (2012) 0.86
An automated method for scanning LC-MS data sets for significant peptides and proteins, including quantitative profiling and interactive confirmation. J Proteome Res (2007) 0.86
Protection of stress-induced impairment of hippocampal/prefrontal LTP through blockade of glucocorticoid receptors: implication of MEK signaling. Exp Neurol (2008) 0.85
Quantitative mapping shows that serotonin rather than dopamine receptor mRNA expressions are affected after repeated intermittent administration of MDMA in rat brain. Neuropharmacology (2006) 0.85
Specific localization of the annexin II heterotetramer in brain lipid raft fractions and its changes in spatial learning. J Neurochem (2004) 0.85
Effect of methylphenidate on dopamine/DARPP signalling in adult, but not young, mice. J Neurochem (2003) 0.84
DARPP-32 involvement in the photic pathway of the circadian system. J Neurosci (2006) 0.84
Increased levels of ubiquitin in the 6-OHDA-lesioned striatum of rats. J Proteome Res (2005) 0.84
Phosphatidylinositol 3-kinase is required for the transcriptional activation of cyclin D2 in BCR activated primary mouse B lymphocytes. Eur J Immunol (2005) 0.84
Identification of annexin II heterotetramer as a plasmin reductase. J Biol Chem (2002) 0.84
Genotoxic agents promote the nuclear accumulation of annexin A2: role of annexin A2 in mitigating DNA damage. PLoS One (2012) 0.84
Pyrylium Salts as Reactive Matrices for MALDI-MS Imaging of Biologically Active Primary Amines. J Am Soc Mass Spectrom (2015) 0.84
Cholesterol depletion reduces serotonin binding and signaling via human 5-HT(7(a)) receptors. Eur J Pharmacol (2006) 0.83
The p11 subunit of annexin II heterotetramer is regulated by basic carboxypeptidase. Biochemistry (2002) 0.83
Coupling surface plasmon resonance to mass spectrometry to discover novel protein-protein interactions. Nat Protoc (2009) 0.83
A noncanonical postsynaptic transport route for a GPCR belonging to the serotonin receptor family. J Neurosci (2012) 0.82
S100B overexpressing mutant mice exhibit prolonged behavioural and biochemical responses towards repeated intermittent binge treatments with MDMA. Int J Neuropsychopharmacol (2008) 0.82
7α-hydroxy-3-oxo-4-cholestenoic acid in cerebrospinal fluid reflects the integrity of the blood-brain barrier. J Lipid Res (2013) 0.82